“A Sensitive Bioanalytical Method Development and Validation of Cabozantinib in Human Plasma by LC-ESI-MS MS”. Brazilian Journal of Pharmaceutical Sciences 54, no. 2 (July 26, 2018): e17163. Accessed May 9, 2024. https://www.revistas.usp.br/bjps/article/view/153781.